Tau brain imaging and driving decline in preclinical Alzheimer disease

In this paper, we looked at brain imaging of 42 research participants who had completed both tau imaging and amyloid imaging. The proteins tau and amyloid are considered two of the main predictors of Alzheimer disease in the brain. We found that those who had both abnormal tau levels and abnormal amyloid levels were more likely to receive a marginal or fail rating on a standardized road test than those who had only abnormal amyloid or who had no abnormal levels.

For more information: Coming soon (article in press)